Masaaki Waragai

4.1k citations

85 papers · 3.0k indexed · 1 hit paper · h-index 30

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 23
- Amyotrophic Lateral Sclerosis Research 7
- Neurological disorders and treatments 7
- Neurological diseases and metabolism 5
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 23
- Amyotrophic Lateral Sclerosis Research 7
- Neurological disorders and treatments 7
- Neurological diseases and metabolism 5
Cellular and Molecular Neuroscience top 2%
- Genetic Neurodegenerative Diseases 12
- Nuclear Receptors and Signaling 12
Physiology top 2%
- Alzheimer's disease research and treatments 29
Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research 9

Co-authors: Makoto Hashimoto Masayo Fujita Eliezer Masliah Shuei Sugama Takahiko Tokuda Takato Takenouchi Yoshiki Takamatsu Jianshe Wei
Cited by: Neurology Cellular and Molecular Neuroscience
Partner nations: Japan United States United Kingdom

In The Last Decade

Masaaki Waragai

83 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

Peers

Countries citing papers authored by Masaaki Waragai

Since Specialization

Citations

This map shows the geographic impact of Masaaki Waragai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Waragai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Waragai more than expected).

Fields of papers citing papers by Masaaki Waragai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Waragai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Waragai. The network helps show where Masaaki Waragai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masaaki Waragai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masaaki Waragai Line = papers co-authored together Masaaki Waragai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reconsideration of Alzheimer’s Disease Therapy from a Viewpoint of Amyloidogenic Evolvability Gilbert Ho,Pei Chen Choo,Masaaki Waragai,Satoshi Inoue,Eliezer Masliah,Makoto Hashimoto	2022	2
2	Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease Makoto Hashimoto,Gilbert Ho,Yoshiki Takamatsu,Ryoko Wada,Shuei Sugama,Takato Takenouchi,Masaaki Waragai,Eliezer Masliah	2019	11
3	Motor and Nonmotor Symptoms of Parkinson’s Disease: Antagonistic Pleiotropy Phenomena Derived fromα-Synuclein Evolvability? Yoshiki Takamatsu,Masayo Fujita,Gilbert Ho,Ryoko Wada,Shuei Sugama,Takato Takenouchi,Masaaki Waragai,Eliezer Masliah,Makoto Hashimoto	2018	14
4	Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates Makoto Hashimoto,Gilbert Ho,Yoshiki Takamatsu,Yuka Shimizu,Shuei Sugama,Takato Takenouchi,Masaaki Waragai,Eliezer Masliah	2018	24
5	Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer’s Disease: A 7-Year Follow-Up Study Masaaki Waragai,Masaru Moriya,Takeshi Nojo	2017	52
6	Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases Yoshiki Takamatsu,Gilbert Ho,Wakako Koike,Shuei Sugama,Takato Takenouchi,Masaaki Waragai,Jianshe Wei,Kazunari Sekiyama,Makoto Hashimoto	2017	23
7	Determination of 3-hydroxypropylmercapturic acid in urine by three column-switching high-performance liquid chromatography with electrochemical detection using a diamond electrode Kyohei Higashi,Mana Shibasaki,Kyoshiro Kuni,Takeshi Uemura,Masaaki Waragai,Kenichi Uemura,Kazuei Igarashi,Toshihiko Toida	2017	4
8	Role of genomics in translational research for Parkinson’s disease Kazunari Sekiyama,Yoshiki Takamatsu,Masaaki Waragai,Makoto Hashimoto	2014	14
9	Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine Madoka Yoshida,Kyohei Higashi,Kyoshiro Kuni,Mutsumi Mizoi,Ryotaro Saiki,Mizuho Nakamura,Masaaki Waragai,Kenichi Uemura,Toshihiko Toida,Keiko Kashiwagi,Kazuei Igarashi	2014	24
10	Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies Akio Sekigawa,Yoshiki Takamatsu,Kazunari Sekiyama,Takato Takenouchi,Shuei Sugama,Masaaki Waragai,Masayo Fujita,Makoto Hashimoto	2013	5
11	Pathobiology of Alzheimer’s disease and biomarker development. Hiroyuki Arai,Nobuyuki Okamura,Masaaki Waragai,Katsutoshi Furukawa,Kazuhiko Yanai,Yukitsuka Kudo	2010	1
12	P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases Takato Takenouchi,Kazunari Sekiyama,Akio Sekigawa,Masayo Fujita,Masaaki Waragai,Shuei Sugama,Yoshifumi Iwamaru,Hiroshi Kitani,Makoto Hashimoto	2010	102
13	Amyloid PET in mild cognitive impairment and Alzheimer’s disease with BF-227: comparison to FDG–PET Katsutoshi Furukawa,Nobuyuki Okamura,Manabu Tashiro,Masaaki Waragai,Shozo Furumoto,Ren Iwata,Kazuhiko Yanai,Yukitsuka Kudo,Hiroyuki Arai	2009	29
14	Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease Masaaki Waragai,Nobuyuki Okamura,Katsutoshi Furukawa,Manabu Tashiro,Shozo Furumoto,Yoshihito Funaki,Motohisa Kato,Ren Iwata,Kazuhiko Yanai,Yukitsuka Kudo,Hiroyuki Arai	2009	38
15	Expression of α-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineage Masaaki Nakai,Masayo Fujita,Masaaki Waragai,Shuei Sugama,Jianshe Wei,Hiroyasu Akatsu,Chiaki Ohtaka‐Maruyama,Haruo Okado,Makoto Hashimoto	2007	98
16	Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases Masaaki Waragai,Tatsuo Yamada,Hiroshi Matsuda	2007	83
17	Ataxin 10 induces neuritogenesis via interaction with G‐protein β2 subunit Masaaki Waragai,Shinichiro Nagamitsu,Weidong Xu,Yu Jiang Li,Xi Lin,Tetsuo Ashizawa	2006	25
18	JNK activation is associated with intracellular β-amyloid accumulation Mikio Shoji,Noboru Iwakami,Sousuke Takeuchi,Masaaki Waragai,Misao Suzuki,Ichiro Kanazawa,Carol F. Lippa,Satoshi Ono,Hitoshi Okazawa	2000	148
19	Serial MRI of extrapontine myelinolysis of the basal ganglia: a case report Masaaki Waragai,Töru Satoh	1998	7
20	Serial MR findings of chronic idiopathic ataxic neuropathy Masaaki Waragai,Yoshinari Takaya,Masataka Hayashi	1997	8

About Masaaki Waragai

Masaaki Waragai is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology, having authored 85 papers that have together received 3.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (23 papers), Genetic Neurodegenerative Diseases (12 papers), Nuclear Receptors and Signaling (12 papers), Dementia and Cognitive Impairment Research (9 papers), Amyotrophic Lateral Sclerosis Research (7 papers), Neurological disorders and treatments (7 papers) and Neurological diseases and metabolism (5 papers). The work is most often cited by research in Neurology (1.2k citations), Neurology (466 citations) and Cellular and Molecular Neuroscience (765 citations). Masaaki Waragai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Makoto Hashimoto, Masayo Fujita, Eliezer Masliah, Shuei Sugama, Takahiko Tokuda, Takato Takenouchi, Yoshiki Takamatsu, Jianshe Wei, Kazunari Sekiyama and Gilbert Ho.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact